← All candidates
No insider filings on record.
8 filings on record.
ZVSAZyVersa Therapeutics, Inc.
—
$0.1070
+8.08% · Sep 14
No insider filings on record.
ZyVersa Therapeutics, Inc. hasn't reported Form 4 activity yet.
Price · 1Y · dailyNo open-market activity in range
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 2×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what ZVSA ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Short % float
Pro
The record
newest first
No insider transactions on file for ZVSA yet.
Context
Earnings · EPS vs forecast
1 of 4 quarters beat
Q3 '24−$2.43 act−$0.83
Q2 '24−$3.31 act+$0.44
Q1 '24−$4.53 act−$0.83
Q4 '23−$1041.80 act−$1020.40
The file stays open
8 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice